Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02998164 · ClinicalTrials.gov registry record · NA
Improving Outcomes Using Technology for Children Who Are DHH
A NA study of Hearing Loss and Language Development, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 154
- Enrollment target
- 2
- Study locations
NCT02998164: Active NA study of Hearing Loss and Language Development, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT02998164 is a NA study of Hearing Loss and Language Development that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 154 participants, below the 6,118-participant average among 58 other Hearing Loss trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02998164, a NA study of Hearing Loss and Language Development, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half of the participants will receive AAC technology with their speech and language therapy and half will continue with their usual care models.
Primary Outcome
Evaluated using the mean length of utterance in morphemes collected from language samples. Assessing change between baseline and 24 weeks.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL augmentative and alternative communication technology
Study Locations (2)
Colorado
- Children's Hospital of Colorado - Aurora
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2016-10 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT02998164 still lists
NCT02998164 is an interventional study that assigns participants to a tested intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap, below the 6,118-participant average among 58 other Hearing Loss trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Hearing Loss appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT02998164 reports a single indexed study location in Colorado, Ohio.
Frequently Asked Questions
What is clinical trial NCT02998164 about?
NCT02998164 is a clinical study titled "Improving Outcomes Using Technology for Children Who Are DHH". This study evaluates the efficacy of using augmentative and alternative communication (AAC) technology for enhancing language development in children who are deaf or hard of hearing. Half of the participants will receive AAC technology with their speech and language therapy and half will continue wi...
What is the current status of trial NCT02998164?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 154 participants. The study started on 2016-10. Estimated completion is 2025-12.
What conditions does trial NCT02998164 study?
This clinical trial studies the following conditions: Hearing Loss, Language Development, Social Behavior.
What interventions are being tested in trial NCT02998164?
The interventions under investigation include: Usual Care (BEHAVIORAL), augmentative and alternative communication technology (BEHAVIORAL).
Who is sponsoring clinical trial NCT02998164?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02998164 being conducted?
This trial has 2 study locations across Colorado, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02998164's enrollment target sits among peer trials
154 27th of 58 higher than 32 of 58 other Hearing Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hearing Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Access and Affordability of Adult Hearing Healthcare
RECRUITING · NA
-
AI Noise Reduction in Phonak Hearing Aids
RECRUITING · NA
-
Investigation of a Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation
RECRUITING · NA
-
Auditory-Cognitive Training to Optimize Outcomes for Older CI Users
RECRUITING · NA
-
Innovations in Hearing Accessibility and Technology (IHAT) Study
RECRUITING · NA
-
Clinical Utility of Residual Hearing in the Cochlear Implant Ear
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia